Dr. Sarah Christine Manitsas, MD

Dr. Manitsas practices at Morton Plant Hospital in Clearwater, Florida, part of BayCare Health System.

Dr. Manitsas' NPI, 1790802155, was assigned on March 23, 2007. Dr. Manitsas graduated from Ohio State College of Medicine in 2002. Dr. Manitsas holds Florida license ME103410.

Dr. Manitsas' primary practice is Morton Plant Hospital, at 300 Pinellas St, Clearwater, FL 33756 in Pinellas County. The practice phone is (727) 462-7000.

Dr. Manitsas' primary practice is Morton Plant Hospital in Clearwater, Florida, part of BayCare Health System. The medical group on file is BayCare Medical Group. Dmand AI also links Dr. Manitsas to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manitsas practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Manitsas' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Manitsas is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Manitsas' licenses on file in 2 states: Florida and Ohio.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastrointestinal bleeding and intestinal diverticulosis among the conditions Dr. Manitsas treats.

CMS data shows 1,378 Medicare services from Dr. Manitsas across 17 procedure codes in 2024, for 404 Medicare patients. Medicare paid $88,070 for them.

CMS counts 404 Medicare patients who saw Dr. Manitsas in 2024. The largest group is 65 to 74, with 168 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Manitsas' median patient age at 71, with 65% women.

In 2024, Dr. Manitsas wrote 893 Medicare Part D claims for 238 patients. 77% of them were for generic drugs. CMS names the drug for 768 of them, across 22 drugs with 11 or more claims each, at $615,760 in total drug cost. In 2023, CMS named 630 claims across 13 drugs.

Dr. Manitsas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 160 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Manitsas, more than 86% of the clinicians it reports for that procedure.

CMS Open Payments shows 274 general payments to Dr. Manitsas from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,401.

Dr. Manitsas graduated from Ohio State College of Medicine in 2002.

Dr. Manitsas is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.